“gene-therapy” Archives

in
Entry Author Date Location
East Coast Biotech Roundup: Zafgen, Decibel, Voyager & More 10/16/15 Boston
Voyager Charts an IPO Course Amid Choppy Biotech Waters 10/11/15 Boston
East Coast Biotech Roundup: CAR-T, Celgene, Aerie, ITCI, IPOs, & More 09/21/15 Boston
Gene Therapy Startup Dimension Tx Takes Crossover Cash to IPO Queue 09/14/15 Boston
Shire Sends Hemophilia Gene Editing Prospects Back to Sangamo 09/02/15 San Francisco
West Coast Biotech Roundup: BioMarin, Tocagen, Medivation, Twelve 08/27/15 San Diego
East Coast Biotech Roundup: WaVe, Shkreli, Intarcia & More 08/21/15 Boston
100 Years But Only One Drug: Sickle Cell Patients Wait For Help 08/18/15 National
Global Blood Thera Nabs $120M IPO, Doubles Share Price On First Day 08/11/15 San Francisco
In Biotech, Everyone’s Going Public. What’s Your Excuse? 07/22/15 National
Biogen R&D Chief Doug Williams Leaves to Run New Cancer Startup 07/10/15 Boston
Tackling Sickle Cell, Global Blood Therapeutics Joins IPO Queue 07/08/15 San Francisco
East Coast Biotech Roundup: Vertex, Biogen, Sarepta, Juno, & More 07/06/15 Boston
Biogen Offers Up To $1 Billion for AGTC’s Ophthalmology Gene Therapy 07/02/15 Boston
East Coast Biotech Roundup: Flagship, SQZ, Epizyme, IPOs & More 06/26/15 Boston
West Coast Biotech Roundup: Avalanche, CytomX, BioMarin, Dubs & More 06/19/15 San Francisco
East Coast Biotech Roundup: XTuit, Spero, Unum, RNAi Feud & More 06/12/15 Boston
East Coast Biotech Roundup: Bluebird, Sarepta, Synlogic & More 05/22/15 Boston
So Far, So Good in Bluebird’s First Glimpse of Sickle Cell Data 05/21/15 Boston
Bluebird, Regulators Map Out Approval Plan For Gene Therapy 05/19/15 Boston
East Coast Biotech Roundup: Vertex, Moderna, Sage, ASCO & More 05/15/15 Boston
Selecta Takes Nanotech to Gene Therapy, Celiac With New Deals 05/13/15 Boston
East Coast Biotech Roundup: NY Bio, Synageva, Kadmon & More 05/08/15 New York
Big Apple Biotech “Bootstraps” Forward at NewYorkBio Meeting 05/05/15 New York
Waksal’s Kadmon Spins Out Gene Therapy Group But Keeps Details Close 05/01/15 New York
Celladon Anticipates Layoffs After Its Gene Therapy Trial Fails 04/27/15 San Diego
Crossovers Arm Jounce With $56M For “Next Step” Immuno-Oncology 04/23/15 Boston
Pop That Bubble: 5 Reasons Biotech Needs A Different Metaphor 04/14/15 National
Hunting for an IPO? Voyager Gets $60M From “Crossover” Backers 04/13/15 Boston
East Coast Biotech Roundup: Cellectis, Bristol, What’s Hot & More 04/13/15 Boston
Page 2 of 7 « previous page · next page »